Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Idiopathic Pruritus”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT03239106
What this trial is testing

A Study Examining the Medication Apremilast as Treatment for Chronic Itch

Who this might be right for
Itch
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT05038982
What this trial is testing

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Who this might be right for
Prurigo NodularisPruritusChronic Pruritus+2 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07833306
What this trial is testing

Efficacy and Safety of ATTO-1310 in the Treatment of Participants With Chronic Pruritus of Unknown Origin

Who this might be right for
Chronic Pruritus of Unknown Origin
Attovia Therapeutics Inc 300
Testing effectiveness (Phase 2)Study completedNCT03858634
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Who this might be right for
Chronic Idiopathic UrticariaChronic Idiopathic PruritusLichen Planus+2 more
Genentech, Inc. 58
Large-scale testing (Phase 3)Looking for participantsNCT05263206
What this trial is testing

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Who this might be right for
Pruritus
Sanofi 284
Large-scale testing (Phase 3)Study completedNCT02161562
What this trial is testing

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 314
Testing effectiveness (Phase 2)Study completedNCT03841331
What this trial is testing

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Who this might be right for
Pruritus
Vyne Therapeutics Inc. 233
Large-scale testing (Phase 3)Looking for participantsNCT07811869
What this trial is testing

Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

Who this might be right for
Chronic Pruritus of Unknown Origin
Novartis Pharmaceuticals 180
Not applicableStudy completedNCT04829578
What this trial is testing

Hypnosis for Chronic Idiopathic Pruritus

Who this might be right for
Chronic Idiopathic Pruritus
Centre Hospitalier Universitaire de Nice 12
Testing effectiveness (Phase 2)UnknownNCT05452343
What this trial is testing

CM310 in Subjects With Chronic Pruritus

Who this might be right for
Chronic Pruritus of Unknown Origin
Keymed Biosciences Co.Ltd 50
Testing effectiveness (Phase 2)Study completedNCT01081574
What this trial is testing

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Who this might be right for
Allergic RhinoconjunctivitisChronic Urticaria
Faes Farma, S.A. 36
Large-scale testing (Phase 3)Looking for participantsNCT07700056
What this trial is testing

Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

Who this might be right for
Chronic Pruritus of Unknown Origin
Novartis Pharmaceuticals 180
Testing effectiveness (Phase 2)Study completedNCT05936567
What this trial is testing

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

Who this might be right for
UrticariaChronic Spontaneous UrticariaChronic Idiopathic Urticaria+3 more
Incyte Corporation 136
Testing effectiveness (Phase 2)Active Not RecruitingNCT07074977
What this trial is testing

Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)

Who this might be right for
Chronic Pruritus of Unknown Origin
Galderma R&D 50